Avid Bioservices Inc (CDMO)

[r622102675]

Re:"Also the recent rebranding of Bavi into an immunotherapy seems like trying to get into a hot field.
Before immunotherapy Bavi was supposed to work through ADCC"
is may 2011 considered recent?

May 26, 2011

Keynote Presentation at Leading European Antibody Conference Highlights Immune Reactivation Mechanisms of Bavituximab
About Bavituximab
Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that represents a new approach to treating cancer. PS is a highly immunosuppressive molecule usually located inside the membrane of healthy cells, but "flips" and becomes exposed on the outside of cells that line tumor blood vessels, creating a specific target for anti-cancer treatments. PS-targeting antibodies target and bind to PS and block this immunosuppressive signal, thereby enabling the immune system to recognize and fight the tumor.
...nice try tho imao...r